Literature DB >> 8461604

A study on postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Y Takesue1, T Yokoyama, T Kodama, T Santou, A Nakamitsu, Y Murakami, Y Imamura, K Miyamoto, M Okita, H Tsumura.   

Abstract

We investigated the production of staphylococcal enterotoxin (SE) with respect to coagulase types by methicillin-resistant Staphylococcus aureus (MRSA). A total of 138 strains of MRSA, which were isolated from clinical materials in the surgical ward between 1983 and 1990, were studied. Coagulase type IV strains produced SE A only, whereas coagulase type II strains were classified into four groups by SE production: SE B producing strains (32.7%), SE C producing strains (29.8%), SE B and C coproducing strains (12.5%), and SE A and C coproducing strains (25.0%). Almost all of the organisms (nine of ten) which were isolated from the feces of patients with MRSA enteritis were SE A and C coproducing strains. The coincidence in time of the prevalence of MRSA enteritis and the isolation SE A and C coproducing strains also demonstrated that these strains caused MRSA enteritis. Although SE C producing strains and SE A and C coproducing strains were simultaneously prevalent in 1990, the former tended to be sensitive while the latter tended to be resistant to minocycline. Considering the variety of antibiotic sensitivity in coagulase type II strains, it is thus considered to be of critical importance for epidemiologic purposes to further characterize isolates by SE typing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461604     DOI: 10.1007/bf00308992

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  [Experiences of postoperative staphylococcal enteritis caused by methicillin-cephem resistant Staphylococcus aureus (MRSA) and the state of the isolation of MRSA].

Authors:  M Takahashi; Y Sato; Y Asanuma; T Narisawa; K Koyama; M Tobita; O Nakagomi
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-04

2.  Toxin involvement in toxic shock syndrome.

Authors:  B A Crass; M S Bergdoll
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

3.  Methicillin-resistant Staphylococcus aureus in nosocomial infections in the surgical ward and operating room.

Authors:  Y Takesue; T Yokoyama; T Kodama; M Fujimoto; M Okita; H Sewake; Y Murakami; Y Imamura; H Tsumura
Journal:  Hiroshima J Med Sci       Date:  1989-12

4.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Toxic shock syndrome: management and long-term sequelae.

Authors:  P J Chesney; B A Crass; M B Polyak; P J Wand; T F Warner; J M Vergeront; J P Davis; R W Tofte; R W Chesney; M S Bergdoll
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.

Authors:  J C de Azavedo; J P Arbuthnott
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Laboratory diagnosis of foodborne diseases.

Authors:  H L Kazal
Journal:  Ann Clin Lab Sci       Date:  1976 Sep-Oct       Impact factor: 1.256

9.  Staphylococcal enterocolitis revisited: cytotoxic properties of Staphylococcus aureus from a neonate with enterocolitis.

Authors:  C D Christie; E Lynch-Ballard; W A Andiman
Journal:  Pediatr Infect Dis J       Date:  1988-11       Impact factor: 2.129

10.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more
  8 in total

1.  A Case of Staphylococcus aureus Enterocolitis: A Rare Entity.

Authors:  Shyam Thakkar; Radheshyam Agrawal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

2.  Colonic Perforation Caused by Methicillin-Resistant Staphylococcus aureus Enteritis After Total Gastrectomy: A Case Report.

Authors:  Kenei Furukawa; Jun Tsutsumi; Sumio Takayama; Hiroshi Mashiko; Hiroaki Shiba; Katsuhiko Yanaga
Journal:  Int Surg       Date:  2015-03

3.  New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection.

Authors:  S Kusachi; Y Sumiyama; J Nagao; K Kawai; Y Arima; Y Yoshida; H Kajiwara; Y Saida; Y Nakamura
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Changes in the agr locus affect enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  Yoichi Sugiyama; Kazuya Okii; Yoshiaki Murakami; Takashi Yokoyama; Yoshio Takesue; Hiroki Ohge; Taijiro Sueda; Eiso Hiyama
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

5.  MRSA enteritis causing a high stoma output in the early postoperative phase after bowel surgery.

Authors:  A I Haq; L J Cook
Journal:  Ann R Coll Surg Engl       Date:  2007-04       Impact factor: 1.891

6.  Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis.

Authors:  T Konishi; Y Idezuki; H Kobayashi; K Shimada; S Iwai; K Yamaguchi; N Shinagawa
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

7.  Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis.

Authors:  Yao Wei; Jianfeng Gong; Weiming Zhu; Dong Guo; Lili Gu; Ning Li; Jieshou Li
Journal:  BMC Infect Dis       Date:  2015-07-11       Impact factor: 3.090

Review 8.  A Case of Postoperative Methicillin-Resistant Staphylococcus aureus Enterocolitis in an 81-Year-Old Man and Review of the Literature.

Authors:  Kapil Gururangan; Marisa K Holubar
Journal:  Am J Case Rep       Date:  2020-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.